A Gata2 intronic enhancer confers its pan-endothelia-specific regulation
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
GATA-2, a transcription factor that has been shown to play important roles in multiple organ systems during embryogenesis, has been ascribed the property of regulating the expression of numerous endothelium-specific genes. However,the transcriptional regulatory hierarchy governing Gata2 activation in endothelial cells has not been fully explored. Here, we document GATA-2 endothelial expression during embryogenesis by following GFP expression in Gata2-GFP knock-in embryos. Using founder transgenic analyses, we identified a Gata2 endothelium enhancer in the fourth intron and found that Gata2 regulation by this enhancer is restricted to the endocardial, lymphatic and vascular endothelium. Whereas disruption of three ETS-binding motifs within the enhancer diminished its activity, the ablation of its single E box extinguished endothelial enhancer-directed expression in transgenic mice. Development of the endothelium is known to require SCL(TAL1), and an SCL-E12 (SCL-Tcfe2a) heterodimer can bind the crucial E box in the enhancer in vitro. Thus, GATA-2 is expressed early in lymphatic, cardiac and blood vascular endothelial cells, and the pan-endothelium-specific expression of Gata2 is controlled by a discrete intronic enhancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178 · cited 2×
“Similarly, targeted disruption of the transcription factor Runx1 eliminates definitive hematopoiesis and results in defective angiogenesis and hemorrhaging throughout the CNS (Wang et al., 1996).”
BackgroundAn essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype
Wigle, J. T., Harvey, N., Detmar, M., Lagutina, I., Grosveld, G., Gunn, M. D., Jackson, D. G., & Oliver, G. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1505 · Cited by 943 · cited 2×
“…the identification of human hereditary-lymphedema causative genes indicate that Prox1, Vegfc, Vegfr3, Foxc2 and Sox18 are requisites to the process (Wigle et al., 2002; Wigle and Oliver, 1999; Fang et al., 2000; Irrthum et al., 2003; Karkkainen et al., 2000; Karkkainen et al., 2004; Petrova et…”
BackgroundAbsence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL
Shivdasani, R. A., Mayer, E. L., & Orkin, S. H. (1995) · Nature · doi:10.1038/373432a0 · Cited by 938 · cited 5×
“An E box-binding factor is required for Gata2 endothelial enhancer activity The transcription factor SCL has been shown to play crucial roles in both hematopoiesis (Shivdasani et al., 1995) and vascular development (Patterson et al.”
BackgroundInfluentialAbsence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene.
Robb, L., Lyons, I., Li, R., Hartley, L., Köntgen, F., Harvey, R. P., Metcalf, D., & Begley, C. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7075 · Cited by 577
Molecular Regulation of the Endothelin-1 Gene by Hypoxia
Yamashita, K., Discher, D. J., Hu, J., Bishopric, N. H., & Webster, K. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011344200 · Cited by 340 · cited 3×
“For example, GATA sites have been implicated in the regulation of the endotheliumspecific genes preproendothelin (immature form of EDN1) (Dorfman et al., 1992; Yamashita et al., 2001), Pecam1 (Gumina et al., 1997), Vegfr2 (Kappel et al., 2000; Minami et al., 2004), eNOS (also known as Nos3 – Mouse Genome Informatics)…”
BackgroundGöttgens, B., Nastos, A., Kinston, S., Piltz, S., Delabesse, E. C. M., Stanley, M., Sanchez, M., Ciau‐Uitz, A., Patient, R., & Green, A. R. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf286 · Cited by 212 · cited 5×
“, 1997), and have also been reported to play prominent roles in endothelium-specific enhancer activity (Gottgens et al., 2002; Kappel et al., 2000).”
BackgroundInfluential
Cited by
Ostergaard, P., Simpson, M. A., Connell, F. C., Steward, C. G., Brice, G., Woollard, W. J., Dafou, D., Kilo, T., Smithson, S., Lunt, P., et al. (2011) · Nature Genetics · doi:10.1038/ng.923 · Cited by 506
Transcriptional Control of Endothelial Cell Development
De Val, S., & Black, B. L. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.014 · Cited by 346
Norrmén, C., Ivanov, K. I., Cheng, J., Zangger, N., Delorenzi, M., Jaquet, M., Miura, N., Puolakkainen, P., Horsley, V., Hu, J., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200901104 · Cited by 340
Kazenwadel, J., Secker, G. A., Liu, Y. J., Rosenfeld, J. A., Wildin, R. S., Cuellar-Rodriguez, J., Hsu, A. P., Dyack, S., Fernandez, C. V., Chong, C.-E., et al. (2012) · Blood · doi:10.1182/blood-2011-08-374363 · Cited by 279
Pimanda, J. E., Ottersbach, K., Knezevic, K., Kinston, S., Chan, W. Y. I., Wilson, N. K., Landry, J.-R., Wood, A. D., Kolb-Kokocinski, A., Green, A. R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707045104 · Cited by 228
Metadata
- Authors
- Khandekar, M., Brandt, W., Zhou, Y., Dagenais, S., Glover, T. W., Suzuki, N., Shimizu, R., Yamamoto, M., Lim, K.-C., & Engel, J. D.
- Venue
- Development
- Publisher
- The Company of Biologists
- Published
- 2007-05-01
- Volume
- 134
- Issue
- 9
- Pages
- 1703-1712
- ISSN
- 0950-1991 (ISSN-L)
- 1477-9129
- OpenAlex
- W2077670119
- Cited by
- 92
- References
- 6
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.